For this, we treated established tumor (n = 6) and normal (n = 3) colon organoids derived from nine independent CRC patients with verteporfin (VP), a YAP/TAZ-specific inhibitor that blocks their interaction with the transcription factor TEAD30,31. Here, YAP1 is linked to neoplasm.